Medallion, which will be led by Donald Deyo, a former Medtronic executive, is developing implantable drug delivery infusion pumps to provide improved safety, connectivity and molecular infusion capabilities, according to the report.
“These capabilities address both the requirements of currently approved clinical indications, as well as enable future expansion into new indications in areas such as diabetes and neurodegenerative disease,” reads the report.
More Articles on the Medical Device Market:
4 Latest Medical Device Recalls
Global Medical Electrode Market to Reach $2B by 2020
Physicians Turning to 3-D Printing to Develop Pediatric Devices
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
